Is BMRN stock a Buy, Sell, or Hold?

Based on our analysis, BMRN is currently a HOLD with moderate confidence. 📊 HOLD: BMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BMRN stock?

Our analysis estimates the fair value range for BMRN to be between $63.07 and $68.29. The current price is $65.68.

What is the analyst price target for BMRN?

The average Wall Street analyst price target for BMRN is $91.42. This implies a potential upside of 39.2% from current levels.

BioMarin Pharmaceuticals (BMRN) Stock: Buy, Sell, or Hold?

BMRN - BioMarin Pharmaceuticals Inc

PHARMACEUTICAL PREPARATIONS

$65.68

0.17 (0.26%) ▲

5d: -1.13%

30d: -6.49%

90d: +18.26%

HOLD

MODERATE Confidence

Protect Your BMRN Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Oct 26, 2026

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 3, 2026 at $66.43 · last confirmed Sep 9, 2026

Strength: 5.5/10

Get Alerted When BMRN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BMRN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$121.01

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$75.14

12.6% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BMRN is currently trading at $65.68, which is considered fair relative to its 30-day fair value range of $63.07 to $68.29. The stock's valuation (Forward PE: 10.0) is in line with its historical norms (9.5). At these levels, the market is pricing in 1.9% annual earnings growth.

Technical Outlook: Technically, BMRN is in a strong uptrend. Immediate support is located at $63.57, while resistance sits at $67.69.

Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $91.42 (+39.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR

Historical Trading Range $63.07 - $68.29

Company Quality Score 58/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 75.7%

Protect Your Profits

Holding BMRN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (59/100)
BULLISH: High volume confirmation
BULLISH: Trading 39.2% below Wall St target ($91.42)
BULLISH: Expecting earnings turnaround to 1.9% growth with 19.9% revenue growth
NEUTRAL: Bottoming setup forming (59/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $63.07 - $68.29

Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $63.57

Resistance Level $67.70

Current Trend Strong Uptrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.04

Wall Street Target $91.42 (+39.2%)

Revenue Growth (YoY) 19.9%

Earnings Growth (YoY) -81.3%

Profit Margin 2.1%

Valuation Premium vs History +1.9% premium

PE vs Historical 10.0 vs 9.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +1.9% (market-implied from PE analysis)

1-Year Target $66.93 (+2%)

2-Year Target $68.20 (+4%)

3-Year Target $69.50 (+6%)

3-Yr Target (if PE normalizes) (PE: 10→10) PE COMPRESSION $65.75 (+0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: 30.2%) $291.30 (+344%)

Base: (SPY PE: 10.0, Growth: 30.2%) $145.02 (+121%)

Bear: (PE: 8.5, Growth: 30.2%) $123.27 (+88%)

📈 Valuation based on Current Earnings

Forward PE: 9.73 | Forward EPS (Implied): $6.75

Bull Case $79.31 (+21%)

Analyst growth 15.0%, PE expands to 10.2

Base Case $65.68 (0%)

Market implied 0.0%, PE stable at 9.7

Bear Case $50.25 (-24%)

Severe decline -15.0%, PE contracts to 8.8

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 13, 2026 6:18 PM ET
Data refreshes hourly during market hours. Next update: 7:18 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BMRN showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BMRN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
INSM Insmed Inc	STRONG BUY 21 analysts	$200	54 HOLD
CRSP Crispr Therapeutics AG	BUY 28 analysts	$88	44 HOLD
CYTK Cytokinetics Inc	STRONG BUY 21 analysts	$110	53 HOLD
CRNX Crinetics Pharmaceutical…	STRONG BUY 17 analysts	$86	46 HOLD
BHVN Biohaven Ltd.	STRONG BUY 16 analysts	$21	48 HOLD

INSM Insmed Inc

54 HOLD

CRSP Crispr Therapeuti…

44 HOLD

CYTK Cytokinetics Inc

53 HOLD

CRNX Crinetics Pharmac…

46 HOLD

BHVN Biohaven Ltd.

48 HOLD

Advanced BMRN Option Strategies

Professional options setups generated by AI based on today's BMRN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BMRN

BMRN Technical Chart BMRN Price Prediction BMRN Earnings Date BMRN Investment Advisor BMRN Fair Price Analyzer BMRN Options Advisor BMRN Options Chain BMRN Options Analysis BMRN Competitors

Compare BMRN with Peers

BMRN vs INCY
Which one to buy?

BMRN vs ALNY
Which one to buy?

BMRN vs VRTX
Which one to buy?

BMRN vs REGN
Which one to buy?

BMRN vs BIIB
Which one to buy?

Create New Comparison View All Competitors

Tradestie